A cancer vaccine could be a reality in a few years, according to the co-founders of BioNTech, a German company, which also manufactured the...

Moderna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...

After the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...

Katalin Kariko and Drew Weissman are being seen as potential winners.

The research, published in The Lancet, found that antibody levels among Hong Kong health workers who have been fully vaccinated with BioNTe...

The new technology was not only lightning fast but also incredibly effective - mRNA Covid vaccines from both Moderna and Pfizer hit the bul...

Various governments, WHO and others have been pushing vaccine makers to transfer technology to companies in Asia and Africa to scale up pro...

Countries in Europe and Asia, as well as South Africa, are limiting or halting use of AstraZeneca's shot over safety concerns. Rollout of J...

The EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer...

The study by the U.S. Centers for Disease Control and Prevention (CDC) evaluated the vaccines' ability to protect against infection, includ...

The drugmaker said it was ready to pursue mRNA on its own following its experience in the past year working on the COVID-19 vaccine, the WS...

Pfizer said it had supplied 65 million doses globally and 29 million doses in the United States as of Jan. 31. It expects to supply 200 mil...

While the findings indicated no need for a new vaccine to tackle the new strains, Pfizer and BioNTech said they would respond if there was ...

The mRNA technology contains instructions for human cells to make proteins that mimic part of the coronavirus, and is used in vaccines from...

The extremely stringent temperature requirement for mRNA vaccines, which is what the Pfizer vaccine candidate is based on, will also make i...

The study will recruit 160 people aged 20 to 85, the companies said in a statement.

Britain's GSK said on Monday it would invest 130 million pounds ($163 million) in German biotech firm CureVac for a 10% stake to work toget...